ENTRY       D09945                      Drug
NAME        Pegdinetanib (USAN/INN)
FORMULA     C468H729N125O139S
EXACT_MASS  10356.3539
MOL_WEIGHT  10362.615
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
EFFICACY    Antineoplastic, Angiogenesis inhibitor, Receptor tyrosine kinase inhibitor
COMMENT     PEGylated peptide
            angiogenesis inhibitor
TARGET      VEGFR2 (KDR) [HSA:3791] [KO:K05098]
  PATHWAY   hsa04370(3791)  VEGF signaling pathway
            hsa04510(3791)  Focal adhesion
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                D09945  Pegdinetanib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               VEGFR family
                VEGFR2 (KDR)
                 D09945  Pegdinetanib (USAN/INN)
DBLINKS     CAS: 906450-24-6
            PubChem: 124490627
///
